These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3160019)

  • 21. Class III beta-tubulin shows unique expression patterns in a variety of neoplastic and non-neoplastic lymphoproliferative disorders.
    Yoon SO; Kim WY; Go H; Paik JH; Kim JE; Kim YA; Huh JR; Jeon YK; Kim CW
    Am J Surg Pathol; 2010 May; 34(5):645-55. PubMed ID: 20220512
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advances in the diagnosis and control of lymphomas.
    Candelaria M
    Salud Publica Mex; 2016 Apr; 58(2):296-301. PubMed ID: 27557389
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lymphoproliferative disorders of the gastrointestinal tract: a review and pragmatic guide to diagnosis.
    Burke JS
    Arch Pathol Lab Med; 2011 Oct; 135(10):1283-97. PubMed ID: 21970484
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lymphoproliferative Diseases of the Gut: A Survival Guide for the General Pathologist.
    Owens SR
    Surg Pathol Clin; 2017 Dec; 10(4):1021-1037. PubMed ID: 29103531
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Histological diversity of reactive and atypical proliferative lymph node lesions in systemic lupus erythematosus patients.
    Kojima M; Motoori T; Asano S; Nakamura S
    Pathol Res Pract; 2007; 203(6):423-31. PubMed ID: 17540509
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of Mega-COMLA (cyclophosphamide, cytarabine, vincristine, and methotrexate followed by leucovorin and prednisone) plus CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) in the treatment of lymphoid neoplasms with very poor prognosis.
    Hainsworth JD; Wolff SN; Stein RS; Greer JP; Cousar JB; Greco FA
    Cancer Treat Rep; 1986 Aug; 70(8):953-8. PubMed ID: 3015406
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Therapeutic results and evolution of Black African patients with follicular lymphoma: Ivory Coast experience].
    Koffi G; Kouakou B; Ndiaye FS; Ndathz E; Sanogo I; Sangare A
    Bull Cancer; 2007 Oct; 94(10):902-6. PubMed ID: 17964984
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Lymphomas in the acquired human immunodeficiency syndrome. Clinical, histological, immunological, and developmental study of 26 patients].
    Pintado V; Gil A; Lavilla P; López-Dupla M; Villar A; Gamallo C; García-Rubio B; Valencia E
    Sangre (Barc); 1992 Apr; 37(2):101-8. PubMed ID: 1621177
    [TBL] [Abstract][Full Text] [Related]  

  • 29. UK CLL Forum, London, 25th October 2001.
    Hamblin TJ
    Leuk Res; 2002 Jun; 26(6):607-9. PubMed ID: 12007510
    [No Abstract]   [Full Text] [Related]  

  • 30. [Border between reactive and neoplastic lymphoproliferative processes].
    Klapper W
    Pathologe; 2013 May; 34(3):185. PubMed ID: 23616143
    [No Abstract]   [Full Text] [Related]  

  • 31. Malignant lymphomas.
    Tindle BH
    Am J Pathol; 1984 Jul; 116(1):119-74. PubMed ID: 6377907
    [No Abstract]   [Full Text] [Related]  

  • 32. Fluorodeoxyglucose positron emission tomography (FDG-PET) for monitoring lymphadenopathy in the autoimmune lymphoproliferative syndrome (ALPS).
    Rao VK; Carrasquillo JA; Dale JK; Bacharach SL; Whatley M; Dugan F; Tretler J; Fleisher T; Puck JM; Wilson W; Jaffe ES; Avila N; Chen CC; Straus SE
    Am J Hematol; 2006 Feb; 81(2):81-5. PubMed ID: 16432855
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A single unit lymphoma experience: outcome in a Cape Town academic centre.
    Wood L; Robinson R; Gavine L; Juritz J; Jacobs P
    Transfus Apher Sci; 2007 Aug; 37(1):93-102. PubMed ID: 17931976
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Chronic lymphoproliferative disorders].
    Salles G
    Rev Prat; 2002 May; 52(9):966-71. PubMed ID: 12063762
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Histologic criteria for distinguishing between benign and malignant extranodal lymphoid infiltrates.
    Burke JS
    Semin Diagn Pathol; 1985 Aug; 2(3):152-62. PubMed ID: 3916552
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The extranodal lymphoid infiltrate: a diagnostic dilemma.
    Knowles DM
    Semin Diagn Pathol; 1985 Aug; 2(3):147-51. PubMed ID: 3916551
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lymphoproliferative disorders and motor neuron disease: an update.
    Gordon PH; Rowland LP; Younger DS; Sherman WH; Hays AP; Louis ED; Lange DJ; Trojaborg W; Lovelace RE; Murphy PL; Latov N
    Neurology; 1997 Jun; 48(6):1671-8. PubMed ID: 9191785
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Chronic lymphoproliferative syndromes with leukemic expression].
    Krsnik Castelló I
    Rev Clin Esp; 1999 Apr; 199 Suppl 1():37-43. PubMed ID: 10422449
    [No Abstract]   [Full Text] [Related]  

  • 39. Splenic marginal zone lymphoma: transformation to diffuse large B-cell lymphoma with isolated cerebral manifestation.
    Thoennissen NH; Keyvani K; Voelker HU; Bremer J; Krug U; Müller-Tidow C; Koch P; Müller-Hermelink HK; Berdel WE
    J Clin Oncol; 2008 Sep; 26(27):4509-11. PubMed ID: 18802164
    [No Abstract]   [Full Text] [Related]  

  • 40. Detection of Epstein-Barr virus in transformations of low-grade B-cell lymphomas after fludarabine treatment.
    Shields DJ; Byrd JC; Abbondanzo SL; Lichy JH; Diehl LF; Aguilera NI
    Mod Pathol; 1997 Nov; 10(11):1151-9. PubMed ID: 9388067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.